Aspira Women's Health CEO Michael Buhle departs; Chairman John Fraser named interim CEO

Aspira Women's Health Inc.

Michael Buhle ceased as CEO effective June 17, 2026; no disagreement with company operations.
Board appointed Chairman John Fraser as Interim CEO and Principal Executive Officer.
Separation agreement with Buhle not yet finalized; Company will file amendment within 4 business days.
John Fraser, age 66, is co-founder and co-portfolio manager of Seamark Capital.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

John Fraser

Interim Chief Executive Officer

AWHL · Aspira Women's Health Inc.

Effective: 2026-06-17
Filed: June 22, 2026, 9:13 AM ET

Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.

Departed

Michael Buhle

Chief Executive Officer

AWHL · Aspira Women's Health Inc.

Effective: 2026-06-17
Successor: John Fraser
Filed: June 22, 2026, 9:13 AM ET

On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Fraser was appointed as Interim Chief Executive Officer at Aspira Women's Health Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Buhle departed as Chief Executive Officer at Aspira Women's Health Inc..

Action: ceased serving
Role: Chief Executive Officer

Exact text from the filing

On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-26-000047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.